Profile
Tamara Newbold worked as Vice President-Chemistry, Manufacturing & Controls at Aratana Therapeutics, Inc..
Ms. Newbold attended The State University of New York where she received an undergraduate degree in 1986.
Former positions of Tamara Newbold
| Companies | Position | End |
|---|---|---|
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | - |
Training of Tamara Newbold
| The State University of New York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Stock Market
- Insiders
- Tamara Newbold
